Fresenius Medical Care recently presented its advances in home dialysis solutions at the China International Import Expo (CIIE) in Shanghai, China. The company showcased new digitalised options that enable patients with end-stage renal disease (ESRD) to perform dialysis in the comfort of their own homes, including the 5008S haemodialysis machine and a new automated peritoneal dialysis machine.
A Fresenius press release states that these new technologies will be backed by the company’s intelligent DiaSmart therapy data management system (TDMS+), which enables healthcare professionals to remotely monitor and manage patients throughout their home dialysis treatments with the intention of standardising operations and improving efficiency.
In April 2020, the first home haemodialysis in mainland China was successfully undertaken using Fresenius’ 5008S machine—as reported in the specialist medical journal Hemodialysis International. The dialysis was performed independently by the patient, confirming the feasibility of this treatment option for patients in China, the release adds.
Through the provision of the 5008S, Fresenius is committed to progressing home haemodialysis in China while meeting the needs of individual patients. The machine offers advanced haemodiafiltration therapy at home with features that ensure safe and simple patient operation. The 5008S can also be operated remotely, allowing nephrologists to monitor their patient’s therapy in real time.
At CIIE, Fresenius also introduced an automated peritoneal dialysis machine to China. This computerised dialysis option is complemented by a comprehensive service that supports patients and healthcare professionals throughout each stage of the treatment pathway—from creating the dialysis access point in hospital and training the patient to perform their own dialysis, to monitoring the patient’s treatment data at home and providing ongoing follow-up.
Alan Chen, executive vice president of Fresenius Medical Care Greater China, said: “This is the third time that Fresenius Medical Care has participated at CIIE. This year, we are showcasing our advanced smart home dialysis solutions, which are backed by the strength of our research and development and our understanding of healthcare professional and patient needs.”
Harry de Wit, CEO of Fresenius Medical Care Asia Pacific, said: “With these innovations, our hope is to provide patients in China with new options to dialyse safely in their own homes in ways that meet their individual needs and that can enhance their quality of life. Fresenius Medical Care will continue to commit to the ongoing development of pioneering medical technologies, and introducing them to the renal care community and patients in China and across Asia Pacific.”